Global Health Limited (Medanta) has intimated the stock exchanges about scheduled meetings with analysts and institutional investors. The disclosure is made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company's management will meet investors and analysts in meetings organized by Prabhudas Lilladher Capital. The meeting is scheduled for August 31, 2026, and will include both one-to-one and group meeting formats. The meetings will be conducted in person at Noida.
The company specifically noted that no unpublished price sensitive information (UPSI) is proposed to be shared during these meetings. The disclosure includes a note that the meeting is subject to change in case of any unforeseen circumstances on the part of analysts, investors, or the company.
The communication was digitally signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035), on August 25, 2026, at 12:41:55 IST. The company's registered office is at E-18, Defence Colony, New Delhi 110024.